What is the appropriate management for a patient with one-and-a-half syndrome?

Management of One-and-a-Half Syndrome

One-and-a-half syndrome requires supportive care with treatment directed at the underlying etiology, as the ocular symptoms typically improve spontaneously within days to weeks in most cases.

Understanding the Condition

One-and-a-half syndrome is a pontine neuro-ophthalmological disorder characterized by:

• Horizontal gaze palsy in one direction (inability to look toward the side of the lesion)
• Internuclear ophthalmoplegia (INO) in the opposite direction (failure of adduction of the ipsilateral eye when looking away from the lesion)
• The only preserved movement is abduction of the contralateral eye, often with nystagmus 1, 2, 3

The lesion is located in the unilateral paramedian pontine tegmentum, affecting both the paramedian pontine reticular formation (PPRF) or abducens nucleus and the ipsilateral medial longitudinal fasciculus (MLF) 1, 2, 3, 4.

Immediate Diagnostic Workup

Urgent neuroimaging is mandatory:

• MRI brain is the preferred modality to identify the pontine lesion, as it provides superior visualization of brainstem structures 1, 2, 4
• If MRI is unavailable, obtain CT brain immediately, but recognize its limitations in detecting small brainstem lesions 2
• The typical finding is a small, restricted lesion in the unilateral paramedian area of the midpontine tegmentum 4

Document the complete neuro-ophthalmologic examination:

• Confirm horizontal gaze palsy toward the side of the lesion 3
• Confirm INO (failure of adduction) when attempting to look away from the lesion 3
• Assess for additional cranial nerve deficits, particularly facial nerve involvement (nuclear-type facial paresis may coexist) 1
• Evaluate for other brainstem signs including ataxia, hemiparesis, or sensory deficits 5

Identify and Treat the Underlying Etiology

The most common causes in order of frequency are:

1. Vascular ischemic stroke (most common) 1, 2, 3, 5

   • Lacunar infarction in the paramedian pontine tegmentum is the typical pattern 1, 4
   • Manage according to acute stroke protocols with consideration for thrombolysis if within the therapeutic window
   • Control vascular risk factors (hypertension is a major contributor) 5

2. Multiple sclerosis (second most common, accounting for 70% in one series) 3

   • Consider demyelinating disease especially in younger patients with relapsing symptoms
   • Initiate corticosteroids for acute demyelinating lesions
   • Refer to neurology for disease-modifying therapy

3. Brainstem hemorrhage 5

   • Manage blood pressure carefully to prevent hematoma expansion
   • Monitor for signs of increased intracranial pressure

4. Brainstem tumor (less common) 1

   • Requires oncologic evaluation and treatment planning

Supportive Management

Symptomatic treatment for diplopia and oscillopsia:

• Eye patching of one eye eliminates diplopia and is the simplest immediate intervention 1
• Reassure the patient that ocular symptoms typically improve within days in most cases 1
• No specific pharmacologic therapy has proven benefit for the eye movement disorder itself

Monitor for complications:

• Watch for progression of brainstem dysfunction
• Assess swallowing function if additional lower cranial nerve involvement develops
• Monitor respiratory status if the lesion extends or affects respiratory centers

Prognosis and Follow-up

Natural history:

• Ocular symptoms improved within days in reported cases of ischemic etiology 1
• The prognosis depends entirely on the underlying cause and extent of brainstem damage 2, 3
• Isolated eye movement disorder without additional brainstem signs generally has better prognosis 1

Common pitfalls to avoid:

• Do not delay neuroimaging—the presence of complete horizontal gaze palsy in one direction with INO in the other should immediately raise suspicion of brainstem pathology 5
• Do not assume the diagnosis without imaging confirmation, as the anatomical proximity of multiple structures can produce variant syndromes 2
• Do not overlook vascular risk factor modification in ischemic cases, as secondary prevention is critical